Filamentous‐Actin‐Mimicking Nanoplatform for Enhanced Cytosolic Protein Delivery

Author:

Xia Yuqiong12,Wu Keyun12,Liu Chang12,Zhao Xuejuan12,Wang Jun1,Cao Jianxia1,Chen Zhaoxu1,Fang Minchao3,Yu Jie4,Zhu Cheng3,Zhang Xianghan12,Wang Zhongliang1ORCID

Affiliation:

1. Lab of Molecular Imaging and Translational Medicine (MITM) Engineering Research Center of Molecular & Neuroimaging Ministry of Education School of Life Science and Technology Xidian University & International Joint Research Center for Advanced Medical Imaging and Intelligent Diagnosis and Treatment Xi'an Shaanxi 710126 P. R. China

2. Guangzhou Institute of Technology Xidian University Guangzhou Guangdong 510555 P. R. China

3. Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures School of Life Sciences Tianjin University 92 Weijin Road, Nankai District Tianjin 300072 P. R. China

4. School of Biology and Engineering Guizhou Medical University Guizhou Guiyang 550025 P. R. China

Abstract

AbstractDespite the potential of protein therapeutics, the cytosolic delivery of proteins with high efficiency and bioactivity remains a significant challenge owing to exocytosis and lysosomal degradation after endocytosis. Therefore, it is important to develop a safe and efficient strategy to bypass endocytosis. Inspired by the extraordinary capability of filamentous‐actin (F‐actin) to promote cell membrane fusion, a cyanine dye assembly‐containing nanoplatform mimicking the structure of natural F‐actin is developed. The nanoplatform exhibits fast membrane fusion to cell membrane mimics and thus enters live cells through membrane fusion and bypasses endocytosis. Moreover, it is found to efficiently deliver protein cargos into live cells and quickly release them into the cytosol, leading to high protein cargo transfection efficiency and bioactivity. The nanoplatform also results in the superior inhibition of tumor cells when loaded with anti‐tumor proteins. These results demonstrate that this fusogenic nanoplatform can be valuable for cytosolic protein delivery and tumor treatment.

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3